what is glp 1 gip GLP-1 & Agonists | Obesity and Diabetes Management | Harrison's updates (22nd Ed.) GIP And GLP-1 Monthly Weight
Description
2025 May 12;9:25424823251342182
A GLP-1 RA with proven cardiovascular benefit is also recommended as an option in patients with T2D and chronic kidney disease (CKD) to mitigate the risk of cardiovascular events
Pharmaceut Med
Supplementary Videos 2, 3 and 4 correspond to principle components 1, 2 and 3, respectively
A new FDA-approved obesity pill could offer a lower-cost alternative to injectable GLP-1 drugs like Ozempic and Mounjaro
To help navigate this shifting environment, pharma companies should consider the following imperatives: GLP1s are expanding far beyond diabetes and obesity
